Please create an account to participate in the Slashdot moderation system


Forgot your password?

Slashdot videos: Now with more Slashdot!

  • View

  • Discuss

  • Share

We've improved Slashdot's video section; now you can view our video interviews, product close-ups and site visits with all the usual Slashdot options to comment, share, etc. No more walled garden! It's a work in progress -- we hope you'll check it out (Learn more about the recent updates).


Getting Kicked Off The My Little Pony Forum 5

Posted by samzenpus
from the too-much-free-time dept.
It's good to see people troll forums other than Slashdot, but the My Little Pony forum? You may as well go down to the senior center with a hacksaw and start shortening canes. My favorite admin post from this thread has to be, "Your picture of Stalin riding a Year3 Limited Edition Starflower inside a German concentration camp was both upsetting and historically inaccurate."

Comment: The dangers of a sensational title (Score 2, Interesting) 168

by Masaq (#23992261) Attached to: Cancer Resistance Technique Moves To Human Trials
A better title would probably be, "Scientists test to make sure that interesting cancer treatment idea doesn't kill human subjects." This appears to be a Stage I clinical trial of an interesting idea, that is at least somewhat biologically plausible. I haven't fully reviewed the pulished data, so I don't feel comfortable saying more than that. However, most of us who work in biology and medicine would agree that our understanding of the immune system is still relatively primitive, so there may be potential cures still lurking in plain site. However, Stage I trials are only the very initial trials in humans - and they evaluate safety as the primary outcome; i.e, trying to make sure we're not going to kill anyone. Stage II trials would attempt to evaluate appropriate dosing, and Stage III trials attempt to compare the new therapy to currently accepted standards. While this may be a breakthrough (and all of us in medicine are always looking for breakthroughs), there are also huge lists of ideas that worked really well in mice, moved on to Stage I, II, and III clinical trials, and failed utterly. This is extremely far from being any sort of cancer cure at this point - though perhaps 20 years from now we'll look back at this as a step towards that goal. I think it's always interesting to hear

"Pascal is Pascal is Pascal is dog meat." -- M. Devine and P. Larson, Computer Science 340